Viral illnesses, and in particular, respiratory viruses, are a salient cause of morbidity and mortality worldwide. Historically, major pandemics have been driven by respiratory viruses. Hence, advancing our understanding of emergent treatments for managing respiratory viral illness could have tremendous public health and economic implications for present and future respiratory viral outbreaks.
The aim of this Research Topic is to generate a useful resource of novel therapeutic approaches to target respiratory viruses and treat symptoms associated with infections, such as, cough, dyspnea, and pulmonary inflammation among others.
Basic, translational and clinical research on viral respiratory pharmacology would be welcome in this collection. This is in view of the fact that many respiratory viruses cause cough and other viral-induced symptoms that, although non-life threatening, have a substantial economic impact while affecting the quality of life of patients.
We welcome review and original research articles, on, but not limited to, the following topics:
- Chlorpheniramine maleate mode of antiviral action against SARS-CoV- 2 (basic science).
- Impact of the incorporation of fluvoxamine into the early outpatient treatment of COVID-19 in Honduras: A Case-Control Study (clinical research).
- Model-based approaches to improve intranasal spray targeting for respiratory viral infections (applied research).
-Usability and clinical feasibility of intranasal spray targeting for respiratory viral infections in a clinical setting (human factors/applied/clinical).
- Potential antiviral activity of sugar alcohols (basic science).
Viral illnesses, and in particular, respiratory viruses, are a salient cause of morbidity and mortality worldwide. Historically, major pandemics have been driven by respiratory viruses. Hence, advancing our understanding of emergent treatments for managing respiratory viral illness could have tremendous public health and economic implications for present and future respiratory viral outbreaks.
The aim of this Research Topic is to generate a useful resource of novel therapeutic approaches to target respiratory viruses and treat symptoms associated with infections, such as, cough, dyspnea, and pulmonary inflammation among others.
Basic, translational and clinical research on viral respiratory pharmacology would be welcome in this collection. This is in view of the fact that many respiratory viruses cause cough and other viral-induced symptoms that, although non-life threatening, have a substantial economic impact while affecting the quality of life of patients.
We welcome review and original research articles, on, but not limited to, the following topics:
- Chlorpheniramine maleate mode of antiviral action against SARS-CoV- 2 (basic science).
- Impact of the incorporation of fluvoxamine into the early outpatient treatment of COVID-19 in Honduras: A Case-Control Study (clinical research).
- Model-based approaches to improve intranasal spray targeting for respiratory viral infections (applied research).
-Usability and clinical feasibility of intranasal spray targeting for respiratory viral infections in a clinical setting (human factors/applied/clinical).
- Potential antiviral activity of sugar alcohols (basic science).